Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer /

Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer / prepared for Agency for Health Care Policy and Research ; prepared by Blue Cross and Blue Shield Association ; Naomi Aronson, program director ... [and others]

Saved in:

Bibliographic Details
Online Access:	Connect to online resource
Corporate Authors:	United States. Agency for Health Care Policy and Research, Blue Cross and Blue Shield Association
Other Authors:	Aronson, Naomi
Other title:	Relative effectiveness and cost effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer.
Format:	Government Document Book
Language:	English
Published:	Rockville, Md. : The Agency, [1999]
Series:	AHCPR pub. ; no. 99-E 0012. Evidence report/technology assessment ; no. 4.
Subjects:	Antiandrogens > Therapeutic use. Prostate > Cancer > Hormone therapy. Prostatic Neoplasms > drug therapy. Antineoplastic Agents, Hormonal > therapeutic use. Cost-Benefit Analysis. Gonadotropin-Releasing Hormone > agonists. Treatment Outcome. Meta-Analysis.

Internet

Connect to online resource

Norlin Library - Government Information - US

Holdings details from Norlin Library - Government Information - US
Call Number:	HE 20.6524:4
HE 20.6524:4	Long missing